Cargando…
Low ERCC1 expression is a good predictive marker in lung adenocarcinoma patients receiving chemotherapy based on platinum in all TNM stages - a single-center study
BACKGROUND: High ERCC1 expression is thought to be related with resistance to chemotherapy based on platinum. The aim of this study was to present our institutional observations regarding to the association of ERCC1 and overall survival (OS) of the lung adenocarcinoma patients who received chemother...
Autores principales: | Piljić Burazer, Marina, Mladinov, Suzana, Matana, Antonela, Kuret, Sendi, Bezić, Joško, Glavina Durdov, Merica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745063/ https://www.ncbi.nlm.nih.gov/pubmed/31521181 http://dx.doi.org/10.1186/s13000-019-0885-2 |
Ejemplares similares
-
The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma – A Retrograde Single-Center Study from Croatia
por: Burazer, Marina Piljić, et al.
Publicado: (2017) -
Trial of a Novel Oral Cannabinoid Formulation in Patients with Hypertension: A Double-Blind, Placebo-Controlled Pharmacogenetic Study
por: Batinic, Ana, et al.
Publicado: (2023) -
Differences in Plasma Cannabidiol Concentrations in Women and Men: A Randomized, Placebo-Controlled, Crossover Study
por: Batinic, Ana, et al.
Publicado: (2023) -
A Case of Unilateral Otologic Symptoms as Initial Manifestations of Granulomatosis With Polyangiitis
por: Batinović, Franko, et al.
Publicado: (2023) -
Expression of PD-L1 Is Associated with Inflammatory Microenvironment in Surgical Specimens of Non-Small Cell Lung Cancer
por: Simundza, Ivan, et al.
Publicado: (2021)